Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 2, 2001, Pages 81-86

  Casonato, A ^a   Pontara, E ^a   Vertolli, U P ^a   Steffan, A ^b   Durante, C ^a   De Marco, L ^b   Sartorello, F ^a   Girolami, A ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Chronic renal failure; Plasma von Willebrand factor; Platelet von Willebrand factor

Indexed keywords

ANTIGEN; COLLAGEN; GLYCOCALICIN; GLYCOPROTEIN IB; OLIGOMER; RECEPTOR; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MALE; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; UREMIA;

ADULT; AGED; BLOOD PLATELETS; CASE-CONTROL STUDIES; DIMERIZATION; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; RENAL DIALYSIS; UREMIA; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0035088033     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700201     Document Type: Article

References (30)

1. Bleeding in renal failure
2. Platelet dysfunction in uraemia: Multifaceted defect partially corrected by dyalisis
3. Defective platelet adhesion on vessel subendothelium in uremic patients
4. Platelet dysfunction in uremia: Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen
5. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect
6. Bleeding in renal failure: Is von Willebrand factor implicated?
7. Treatment of the bleeding tendency in uremia with cryoprecipitate
8. Bleeding in renal failure: A possible cause
9. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure
10. Platelet von Willebrand factor: An important determinant of the bleeding time in type I von Willebrand disease
11. Plasma and platelet von Willebrand factor defects in uremia
12. Absence of high molecular weight von Willebrand factor (HMWvWF) before and after hemodialysis despite a decrease in bleeding time
13. Multimeric pattern of plasma and platelet von Willebrand factor is normal in uremic patients
14. Conjugated estrogens for the management of bleeding associated with renal failure
15. Von Willebrand factor binding to collagen in patients with end-stage renal disease
16. Reduction of platelet glycoprotein Ib in uraemia
17. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia
18. Uremic platelets have a functional defect affecting the interaction of von Willebrand factor with glycoprotein IIb-IIIa
19. Analysis of platelet abnormalities in uremia with and without Glanzmann's thromboasthenia
20. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis
21. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma
22. The evaluation of factor VIII antigen by means of a simple slide test
23. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content
24. A new congenital haemorrhagic condition due to the presence of abnormal factor X (factor X Friuli): Study of a large kindred
25. Isolation and characterization of the von Willebrand factor-binding domain between residues His-Arg 293 of the alpha-chain of glycoprotein Ib
26. Glycocalicin: A new assay - The normal plasma levels and its potential usefulness in selected disease
27. Abnormal collagen binding activity of 2A von Willebrand factor: Evidence that the defect depends only on the lack of large multimers
28. Von Willebrand factor binding to collagen in patients with end-stage renal disease
29. High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood
30. The effect of ABO group on the diagnosis of vWD